Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion.

"Declarations Ethics approval and consent to participateOur study was carried out according to the Declaration of Helsinki (2013 EDITION) and was approved by the Ethics Committee of West China Hospital (No. 2022 − 1085). Individual consent for this study was waived by the Ethics Committee of West China Hospital as the privacy of the patients has not been disclosed. All methods were carried out following relevant guidelines and regulations. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China [Grant numbers 82072598, 81871890 and 91859203]; 1-3-5 project for disciplines of excellence, West China Hospital, Sichuan University, China [Grant numbers, ZYJC21052]; National Key Development Plan for Precision Medicine Research of China [Grant numbers, 2017YFC0910004], Science and Technology Program of Sichuan, China [Grant numbers, 2020YFS0572]; Major Science and Technology Innovation Project of Chengdu City, China [Grant numbers, 2020-YF08-00080-GX]; and Central Guide Place-Free Exploration Project, Sichuan Provincial Department of Science and Technology, China [Grant numbers, 2020ZYD005]."